| Outcome Measures: |
Primary: Difference in skin irritation before and after regular application of nsFP according to the modified Draize scale., Erythema and edema were assessed for adhesive and sensor-insertion areas on a 4-point scale, with total score ≤3 defined as mild, 4-5 as moderate, and 6-8 as severe., 2 years from patient first enrollment | Secondary: Change in BMI SDS, Weight (kg), height (meters), age (years) and sex will be combined to report BMI SDS, 6 months after nsFP use|Change in height SDS 6 months after nsFP use, Height (meters), age (years) and sex will be combined to report height SDS, 6 months after nsFP use.|Change in mean glucose 6 months after nsFP use, Mean glucose measured as mg/dl, 6 months after nsFP use.|Change in glycated hemoglobin 6 months after nsFP use, Glycated hemoglobin measured with the DCCT (Diabetes Control and Complications Trial) units, presented as percentage The new mmols/mol values are known as the IFCC (International Federation of Clinical Chemistry) units., 6 months after nsFP use.
|
